0.4598
-0.0392
(-7.86%)
At close: January 31 at 4:00:01 PM EST
0.4568
-0.00
(-0.65%)
After hours: 7:41:29 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 4 | 4 |
| Avg. Estimate | -0.16 | -0.18 | -1.2 | -0.62 |
| Low Estimate | -0.28 | -0.28 | -1.32 | -1 |
| High Estimate | -0.08 | -0.08 | -1.12 | -0.29 |
| Year Ago EPS | -0.48 | -0.46 | -2.59 | -1.2 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 4 | 4 |
| Avg. Estimate | 5.42M | 4.69M | 21.41M | 20.32M |
| Low Estimate | 3.38M | 3.38M | 19.36M | 14.59M |
| High Estimate | 8M | 6M | 24M | 25M |
| Year Ago Sales | 4.29M | 3.4M | 14.92M | 21.41M |
| Sales Growth (year/est) | 26.40% | 38.14% | 43.48% | -5.06% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.39 | -0.36 | -0.36 |
| EPS Actual | -0.48 | -0.46 | -0.27 | -0.31 |
| Difference | 0.06 | -0.07 | 0.09 | 0.05 |
| Surprise % | 11.66% | -18.96% | 25.00% | 13.89% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.16 | -0.18 | -1.2 | -0.62 |
| 7 Days Ago | -0.19 | -0.28 | -1.23 | -0.54 |
| 30 Days Ago | -0.19 | -0.25 | -1.23 | -0.54 |
| 60 Days Ago | -0.16 | -0.33 | -1.2 | -0.76 |
| 90 Days Ago | -0.37 | -0.33 | -1.53 | -1.38 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 1 |
| Up Last 30 Days | 1 | -- | -- | 1 |
| Down Last 7 Days | -- | 1 | -- | -- |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CARM | 66.15% | 60.87% | 53.67% | 48.12% |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 1/17/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/13/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/16/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 12/12/2024 |
| Downgrade | Baird: Outperform to Neutral | 12/12/2024 |
| Downgrade | Evercore ISI Group: Outperform to In-Line | 12/11/2024 |
Related Tickers
PCSA Processa Pharmaceuticals, Inc.
0.6500
-0.75%
PTIX Protagenic Therapeutics, Inc.
0.3690
-5.63%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.7263
-9.21%
ENVB Enveric Biosciences, Inc.
2.0900
-46.41%
OCEA Ocean Biomedical, Inc.
0.1961
+3.48%
ONCO Onconetix, Inc.
0.5442
-3.66%
TVGN Tevogen Bio Holdings Inc.
1.4900
+11.19%
XFOR X4 Pharmaceuticals, Inc.
0.7001
+5.74%
KZIA Kazia Therapeutics Limited
1.5800
-16.84%
ATHE Alterity Therapeutics Limited
4.8000
+5.03%